257 related articles for article (PubMed ID: 1440381)
1. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
[No Abstract] [Full Text] [Related]
2. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
López-Brea M; Alarcón T
Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
[No Abstract] [Full Text] [Related]
3. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
[No Abstract] [Full Text] [Related]
4. Peptic ulcer treatment today--is there a role for maintenance therapy?
Breslin NP; O'Morain C
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
[No Abstract] [Full Text] [Related]
5. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N
Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to recurrent peptic ulcer disease.
Cave DR
Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
[No Abstract] [Full Text] [Related]
8. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
[TBL] [Abstract][Full Text] [Related]
9. [Infections caused by Helicobacter pylori].
Stock I; Wiedemann B
Med Monatsschr Pharm; 1997 Jan; 20(1):2-8. PubMed ID: 9082155
[No Abstract] [Full Text] [Related]
10. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
Fedotin MS
Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
[TBL] [Abstract][Full Text] [Related]
11. Management of Helicobacter pylori-positive peptic ulcer disease.
Malfertheiner P
Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
[No Abstract] [Full Text] [Related]
12. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Peura DA; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
[No Abstract] [Full Text] [Related]
15. Treatment of Helicobacter pylori infection.
Ebell MH
J Fam Pract; 1996 Jun; 42(6):568. PubMed ID: 8656165
[No Abstract] [Full Text] [Related]
16. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
Tsuji S; Kawano S
J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
[No Abstract] [Full Text] [Related]
17. [Chronic duodenitis associating with Helicobacter pylori].
Konorev MR; Litviakov AM; Krylov IuV; Matveenko ME; Kovalev AV; Riashchikov AA
Klin Med (Mosk); 1999; 77(11):49-51. PubMed ID: 10635636
[No Abstract] [Full Text] [Related]
18. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
[No Abstract] [Full Text] [Related]
19. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
Lux G
Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
[No Abstract] [Full Text] [Related]
20. [Treatment of Helicobacter pylori infection in adults].
Boixeda D
Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
[No Abstract] [Full Text] [Related]
[Next] [New Search]
